These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15711424)

  • 1. Incidence and management of "no-reflow" following percutaneous coronary interventions.
    Kelly RV; Cohen MG; Stouffer GA
    Am J Med Sci; 2005 Feb; 329(2):78-85. PubMed ID: 15711424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epicardial and microvascular reperfusion with primary percutaneous coronary intervention.
    Bolognese L; Falsini G; Liistro F; Angioli P; Ducci K
    Ital Heart J; 2005 Jun; 6(6):447-52. PubMed ID: 16008148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracoronary adenosine administered during percutaneous intervention in acute myocardial infarction and reduction in the incidence of "no reflow" phenomenon.
    Assali AR; Sdringola S; Ghani M; Denkats AE; Yepes A; Hanna GP; Schroth G; Fujise K; Anderson HV; Smalling RW; Rosales OR
    Catheter Cardiovasc Interv; 2000 Sep; 51(1):27-31; discussion 32. PubMed ID: 10973014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The no-reflow phenomenon in coronary arteries.
    Kelly RV; Cohen MG; Runge MS; Stouffer GA
    J Thromb Haemost; 2004 Nov; 2(11):1903-7. PubMed ID: 15550020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic intragraft injection of nicardipine prior to saphenous vein graft percutaneous intervention for the prevention of no-reflow: a review and comparison to protection devices.
    Habibzadeh MR; Thai H; Movahed MR
    J Invasive Cardiol; 2011 May; 23(5):202-6. PubMed ID: 21562350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Features and outcome of no-reflow after percutaneous coronary intervention.
    Abbo KM; Dooris M; Glazier S; O'Neill WW; Byrd D; Grines CL; Safian RD
    Am J Cardiol; 1995 Apr; 75(12):778-82. PubMed ID: 7717278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of the no-reflow phenomenon after coronary angioplasty for acute myocardial infarction with intracoronary papaverine.
    Ishihara M; Sato H; Tateishi H; Kawagoe T; Shimatani Y; Kurisu S; Sakai K
    Am Heart J; 1996 Nov; 132(5):959-63. PubMed ID: 8892767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized evaluation of intracoronary nitroprusside vs. adenosine after thrombus aspiration during primary percutaneous coronary intervention for the prevention of no-reflow in acute myocardial infarction: the REOPEN-AMI study protocol.
    Niccoli G; D'amario D; Spaziani C; Cosentino N; Marino M; Rigattieri S; Schiavo PL; De Vita MR; Tarantino F; Bartorelli A; Fabbiocchi F; Prati F; Imola F; Valgimigli M; Ferrari R; Crea F
    J Cardiovasc Med (Hagerstown); 2009 Jul; 10(7):585-92. PubMed ID: 19384242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological management of no reflow during percutaneous coronary intervention.
    Porto I; Ashar V; Mitchell AR
    Curr Vasc Pharmacol; 2006 Apr; 4(2):95-100. PubMed ID: 16611152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanical thrombectomy options in complex percutaneous coronary interventions.
    Kelly RV; Cohen MG; Stouffer GA
    Catheter Cardiovasc Interv; 2006 Dec; 68(6):917-28. PubMed ID: 17086518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of the no-reflow phenomenon.
    Butler MJ; Chan W; Taylor AJ; Dart AM; Duffy SJ
    Pharmacol Ther; 2011 Oct; 132(1):72-85. PubMed ID: 21664376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention and treatment of microvascular obstruction-related myocardial injury and coronary no-reflow following percutaneous coronary intervention: a systematic approach.
    Jaffe R; Dick A; Strauss BH
    JACC Cardiovasc Interv; 2010 Jul; 3(7):695-704. PubMed ID: 20650430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of ST-segment elevation myocardial infarction (CICERO) trial.
    Gu YL; Kampinga MA; Wieringa WG; Fokkema ML; Nijsten MW; Hillege HL; van den Heuvel AF; Tan ES; Pundziute G; van der Werf R; Hoseyni Guyomi S; van der Horst IC; Zijlstra F; de Smet BJ
    Circulation; 2010 Dec; 122(25):2709-17. PubMed ID: 21098442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix Metalloproteinase-9 in the Culprit Coronary Artery and Myocardial No-Reflow.
    Dong M; Mu N; Ren F; Li F; Zhang C; Yang J
    Am J Med Sci; 2015 Nov; 350(5):352-6. PubMed ID: 26359995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of high-dose intracoronary adenosine administration during primary percutaneous coronary intervention in acute myocardial infarction: a randomized controlled trial.
    Fokkema ML; Vlaar PJ; Vogelzang M; Gu YL; Kampinga MA; de Smet BJ; Jessurun GA; Anthonio RL; van den Heuvel AF; Tan ES; Zijlstra F
    Circ Cardiovasc Interv; 2009 Aug; 2(4):323-9. PubMed ID: 20031735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous coronary intervention and the no-reflow phenomenon.
    van Gaal WJ; Banning AP
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):715-31. PubMed ID: 17605650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of intra-coronary injection of anisodamine on the slow-reflow phenomenon in patients with acute myocardial infarction after percutaneous coronary intervention].
    Wei YY; Fu XH; Liu J
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Apr; 28(4):295-9. PubMed ID: 18543478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of no-reflow and impaired flow with the nitric oxide donor nitroprusside following percutaneous coronary interventions: initial human clinical experience.
    Hillegass WB; Dean NA; Liao L; Rhinehart RG; Myers PR
    J Am Coll Cardiol; 2001 Apr; 37(5):1335-43. PubMed ID: 11300444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized comparison of primary percutaneous coronary intervention with combined proximal embolic protection and thrombus aspiration versus primary percutaneous coronary intervention alone in ST-segment elevation myocardial infarction: the PREPARE (PRoximal Embolic Protection in Acute myocardial infarction and Resolution of ST-Elevation) study.
    Haeck JD; Koch KT; Bilodeau L; Van der Schaaf RJ; Henriques JP; Vis MM; Baan J; Van der Wal AC; Piek JJ; Tijssen JG; Krucoff MW; De Winter RJ
    JACC Cardiovasc Interv; 2009 Oct; 2(10):934-43. PubMed ID: 19850252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjunctive thrombectomy and distal protection in primary percutaneous coronary intervention: impact on microvascular perfusion and outcomes.
    Srinivasan M; Rihal C; Holmes DR; Prasad A
    Circulation; 2009 Mar; 119(9):1311-9. PubMed ID: 19273732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.